Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Imeglimin Beneficial As Add-On to Metformin in T2DM
As add-on therapy, new oral agent improves glycemic control; generally well tolerated
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

September 1, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Modest Predictive Accuracy for CHA2DS2-VASc in Heart Failure

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

Consensus for Early Peanut Exposure in High-Risk Infants

AAP: In Office Visits, Ask Every Adolescent About Alcohol Use

Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use

Intravenous Cyclosporine Doesn't Improve STEMI Outcomes